-
1
-
-
33845775666
-
HIV and antiretroviral therapy in the brain: Neuronal injury and repair
-
[1] Ellis R, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 2007; 8(1): 33-44.
-
(2007)
Nat Rev Neurosci
, vol.8
, Issue.1
, pp. 33-44
-
-
Ellis, R.1
Langford, D.2
Masliah, E.3
-
2
-
-
0031470192
-
Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center
-
[2] Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 1997; 42(6): 963-972.
-
(1997)
Ann Neurol
, vol.42
, Issue.6
, pp. 963-972
-
-
Masliah, E.1
Heaton, R.K.2
Marcotte, T.D.3
Ellis, R.J.4
Wiley, C.A.5
Mallory, M.6
Achim, C.L.7
McCutchan, J.A.8
Nelson, J.A.9
Atkinson, J.H.10
-
3
-
-
0022522203
-
Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
-
[3] Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233(4768): 1089-1093.
-
(1986)
Science
, vol.233
, Issue.4768
, pp. 1089-1093
-
-
Koenig, S.1
Gendelman, H.E.2
Orenstein, J.M.3
Dal Canto, M.C.4
Pezeshkpour, G.H.5
Yungbluth, M.6
Janotta, F.7
Aksamit, A.8
Martin, M.A.9
Fauci, A.S.10
-
4
-
-
0022263807
-
Multinucleated giant cells and HTLV-III in AIDS encephalopathy
-
[4] Sharer LR, Cho ES, Epstein LG. Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum Pathol 1985; 16(8): 760.
-
(1985)
Hum Pathol
, vol.16
, Issue.8
, pp. 760
-
-
Sharer, L.R.1
Cho, E.S.2
Epstein, L.G.3
-
5
-
-
0000969952
-
Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients
-
[5] Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 1986; 83(18): 7089-7093.
-
(1986)
Proc Natl Acad Sci U S A
, vol.83
, Issue.18
, pp. 7089-7093
-
-
Wiley, C.A.1
Schrier, R.D.2
Nelson, J.A.3
Lampert, P.W.4
Oldstone, M.B.5
-
6
-
-
0023250558
-
Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy
-
[6] Gyorkey F, Melnick JL, Gyorkey P. Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy. J Infect Dis 1987; 155(5): 870-876.
-
(1987)
J Infect Dis
, vol.155
, Issue.5
, pp. 870-876
-
-
Gyorkey, F.1
Melnick, J.L.2
Gyorkey, P.3
-
7
-
-
0025335643
-
Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS)
-
[7] Budka H. Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS). Acta Neuropathol 1990; 79(6): 611-619.
-
(1990)
Acta Neuropathol
, vol.79
, Issue.6
, pp. 611-619
-
-
Budka, H.1
-
8
-
-
0026041114
-
Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(S) or by the cytokines tumor necrosis factor alpha and interleukin-1β
-
[8] Tornatore C, Nath A, Amemiya K, Major EO. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1β. J Virol 1991; 65(11): 6094-6100.
-
(1991)
J Virol
, vol.65
, Issue.11
, pp. 6094-6100
-
-
Tornatore, C.1
Nath, A.2
Amemiya, K.3
Major, E.O.4
-
9
-
-
0022523023
-
The AIDS dementia complex: II. Neuropathology
-
[9] Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986; 19(6): 525-535.
-
(1986)
Ann Neurol
, vol.19
, Issue.6
, pp. 525-535
-
-
Navia, B.A.1
Cho, E.S.2
Petito, C.K.3
Price, R.W.4
-
10
-
-
0023779831
-
Microglia in the giant cell encephalitis of acquired immune deficiency syndrome: Proliferation, infection and fusion
-
[10] Michaels J, Price RW, Rosenblum MK. Microglia in the giant cell encephalitis of acquired immune deficiency syndrome: proliferation, infection and fusion. Acta Neuropathol 1988; 76(4): 373-379.
-
(1988)
Acta Neuropathol
, vol.76
, Issue.4
, pp. 373-379
-
-
Michaels, J.1
Price, R.W.2
Rosenblum, M.K.3
-
11
-
-
0024762317
-
Neuropathological changes in early HIV-1 dementia
-
[11] McArthur JC, Becker PS, Parisi JE, Trapp B, Selnes OA, Cornblath DR, Balakrishnan J, Griffin JW, Price D. Neuropathological changes in early HIV-1 dementia. Ann Neurol 1989; 26(5): 681-684.
-
(1989)
Ann Neurol
, vol.26
, Issue.5
, pp. 681-684
-
-
McArthur, J.C.1
Becker, P.S.2
Parisi, J.E.3
Trapp, B.4
Selnes, O.A.5
Cornblath, D.R.6
Balakrishnan, J.7
Griffin, J.W.8
Price, D.9
-
12
-
-
0025963498
-
Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains
-
[12] Pulliam L, Herndier BG, Tang NM, McGrath MS. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest 1991; 87(2): 503-512.
-
(1991)
J Clin Invest
, vol.87
, Issue.2
, pp. 503-512
-
-
Pulliam, L.1
Herndier, B.G.2
Tang, N.M.3
McGrath, M.S.4
-
13
-
-
0034759909
-
Human immunodeficiency virus type-1 Tat protein induces nuclear factor (NF)-κB activation and oxidative stress in microglial cultures by independent mechanisms
-
[13] Nicolini A, Ajmone-Cat MA, Bernardo A, Levi G, Minghetti L. Human immunodeficiency virus type-1 Tat protein induces nuclear factor (NF)-κB activation and oxidative stress in microglial cultures by independent mechanisms. J Neurochem 2001; 79(3): 713-716.
-
(2001)
J Neurochem
, vol.79
, Issue.3
, pp. 713-716
-
-
Nicolini, A.1
Ajmone-Cat, M.A.2
Bernardo, A.3
Levi, G.4
Minghetti, L.5
-
14
-
-
27744450714
-
HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations
-
[14] Pocernich CB, Sultana R, Mohmmad-Abdul H, Nath A, Butterfield DA. HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations. Brain Res Rev 2005; 50(1): 14-26.
-
(2005)
Brain Res Rev
, vol.50
, Issue.1
, pp. 14-26
-
-
Pocernich, C.B.1
Sultana, R.2
Mohmmad-Abdul, H.3
Nath, A.4
Butterfield, D.A.5
-
15
-
-
0037469162
-
Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants
-
[15] Turchan J, Pocernich CB, Gairola C, Chauhan A, Schifitto G, Butterfield DA, Buch S, Narayan O, Sinai A, Geiger J et al. Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 2003; 60(2): 307-314.
-
(2003)
Neurology
, vol.60
, Issue.2
, pp. 307-314
-
-
Turchan, J.1
Pocernich, C.B.2
Gairola, C.3
Chauhan, A.4
Schifitto, G.5
Butterfield, D.A.6
Buch, S.7
Narayan, O.8
Sinai, A.9
Geiger, J.10
-
16
-
-
18244409652
-
Hauser KF. Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat
-
[16] El-Hage N, Gurwell JA, Singh IN, Knapp PE, Nath A, Hauser KF. Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia 2005; 50(2): 91-106.
-
(2005)
Glia
, vol.50
, Issue.2
, pp. 91-106
-
-
El-Hage, N.1
Gurwell, J.A.2
Singh, I.N.3
Knapp, P.E.4
Nath, A.5
-
17
-
-
0027458469
-
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation
-
[17] Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 1993; 67(1): 277-287.
-
(1993)
J Virol
, vol.67
, Issue.1
, pp. 277-287
-
-
Ensoli, B.1
Buonaguro, L.2
Barillari, G.3
Fiorelli, V.4
Gendelman, R.5
Morgan, R.A.6
Wingfield, P.7
Gallo, R.C.8
-
18
-
-
0036891081
-
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia
-
[18] Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 2002; 186 Suppl 2: S193-198.
-
J Infect Dis 2002; 186 Suppl
, vol.2
, pp. S193-S198
-
-
Nath, A.1
-
19
-
-
0027439572
-
Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity
-
[19] Lipton SA. Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol 1993; 33(2): 227-228.
-
(1993)
Ann Neurol
, vol.33
, Issue.2
, pp. 227-228
-
-
Lipton, S.A.1
-
20
-
-
0032847276
-
Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat
-
[20] Haughey NJ, Holden CP, Nath A, Geiger JD. Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat. J Neurochem 1999; 73(4): 1363-1374.
-
(1999)
J Neurochem
, vol.73
, Issue.4
, pp. 1363-1374
-
-
Haughey, N.J.1
Holden, C.P.2
Nath, A.3
Geiger, J.D.4
-
21
-
-
34147123616
-
HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration
-
[21] Jones GJ, Barsby NL, Cohen EA, Holden J, Harris K, Dickie P, Jhamandas J, Power C. HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration. J Neurosci 2007; 27(14): 3703-3711.
-
(2007)
J Neurosci
, vol.27
, Issue.14
, pp. 3703-3711
-
-
Jones, G.J.1
Barsby, N.L.2
Cohen, E.A.3
Holden, J.4
Harris, K.5
Dickie, P.6
Jhamandas, J.7
Power, C.8
-
22
-
-
0023786731
-
Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide
-
[22] Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 1988; 335(6191): 639-642.
-
(1988)
Nature
, vol.335
, Issue.6191
, pp. 639-642
-
-
Brenneman, D.E.1
Westbrook, G.L.2
Fitzgerald, S.P.3
Ennist, D.L.4
Elkins, K.L.5
Ruff, M.R.6
Pert, C.B.7
-
23
-
-
0030889331
-
Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures
-
[23] New DR, Ma M, Epstein LG, Nath A, Gelbard HA. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol 1997; 3(2): 168-173.
-
(1997)
J Neurovirol
, vol.3
, Issue.2
, pp. 168-173
-
-
New, D.R.1
Ma, M.2
Epstein, L.G.3
Nath, A.4
Gelbard, H.A.5
-
24
-
-
0032926464
-
Molecular pathway involved in HIV-1-induced CNS pathology: Role of viral regulatory protein, Tat
-
[24] Rappaport J, Joseph J, Croul S, Alexander G, Del Valle L, Amini S, Khalili K. Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukoc Biol 1999; 65(4): 458-465.
-
(1999)
J Leukoc Biol
, vol.65
, Issue.4
, pp. 458-465
-
-
Rappaport, J.1
Joseph, J.2
Croul, S.3
Alexander, G.4
Del Valle, L.5
Amini, S.6
Khalili, K.7
-
25
-
-
77956544206
-
Interactive comorbidity between opioid drug abuse and HIV-1 Tat: Chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons
-
[25] Fitting S, Xu R, Bull C, Buch SK, El-Hage N, Nath A, Knapp PE, Hauser KF. Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am J Pathol 2010; 177(3): 1397-1410.
-
(2010)
Am J Pathol
, vol.177
, Issue.3
, pp. 1397-1410
-
-
Fitting, S.1
Xu, R.2
Bull, C.3
Buch, S.K.4
El-Hage, N.5
Nath, A.6
Knapp, P.E.7
Hauser, K.F.8
-
26
-
-
84907148350
-
Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na+ influx, mitochondrial instability, and Ca2+ overload
-
[26] Fitting S, Knapp PE, Zou S, Marks WD, Bowers MS, Akbarali HI, Hauser KF. Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na+ influx, mitochondrial instability, and Ca2+ overload. J Neurosci 2014; 34(38): 12850-12864.
-
(2014)
J Neurosci
, vol.34
, Issue.38
, pp. 12850-12864
-
-
Fitting, S.1
Knapp, P.E.2
Zou, S.3
Marks, W.D.4
Bowers, M.S.5
Akbarali, H.I.6
Hauser, K.F.7
-
27
-
-
84903398771
-
Morphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neurites
-
Masvekar RR, El-Hage N, Hauser KF, Knapp PE. Morphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neurites. PLoS One 2014; 9(6): e100196.
-
(2014)
Plos One
, vol.9
, Issue.6
-
-
Masvekar, R.R.1
El-Hage, N.2
Hauser, K.F.3
Knapp, P.E.4
-
28
-
-
83755224872
-
Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia
-
[28] Zou S, Fitting S, Hahn YK, Welch SP, El-Hage N, Hauser KF, Knapp PE. Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia. Brain 2011; 134(Pt 12): 3613-3628.
-
(2011)
Brain
, vol.134
, Issue.12
, pp. 3613-3628
-
-
Zou, S.1
Fitting, S.2
Hahn, Y.K.3
Welch, S.P.4
El-Hage, N.5
Hauser, K.F.6
Knapp, P.E.7
-
29
-
-
84866335871
-
Opiate drug use and the pathophysiology of neuroAIDS
-
[29] Hauser KF, Fitting S, Dever SM, Podhaizer EM, Knapp PE. Opiate drug use and the pathophysiology of neuroAIDS. Curr HIV Res 2012, 10(5): 435-452.
-
(2012)
Curr HIV Res
, vol.10
, Issue.5
, pp. 435-452
-
-
Hauser, K.F.1
Fitting, S.2
Dever, S.M.3
Podhaizer, E.M.4
Knapp, P.E.5
-
30
-
-
84906730315
-
Interactions of HIV and drugs of abuse: The importance of glia, neural progenitors, and host genetic factors
-
[30] Hauser KF, Knapp PE. Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors. Int Rev Neurobiol 2014; 118: 231-313.
-
(2014)
Int Rev Neurobiol
, vol.118
, pp. 231-313
-
-
Hauser, K.F.1
Knapp, P.E.2
-
31
-
-
0028044732
-
Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: Implications for AIDS dementia complex
-
[31] Benos DJ, Hahn BH, Bubien JK, Ghosh SK, Mashburn NA, Chaikin MA, Shaw GM, Benveniste EN. Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Proc Natl Acad Sci U S A 1994; 91(2): 494-498.
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, Issue.2
, pp. 494-498
-
-
Benos, D.J.1
Hahn, B.H.2
Bubien, J.K.3
Ghosh, S.K.4
Mashburn, N.A.5
Chaikin, M.A.6
Shaw, G.M.7
Benveniste, E.N.8
-
32
-
-
0032539828
-
Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia
-
[32] Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A 1998; 95(6): 3117-3121.
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, Issue.6
, pp. 3117-3121
-
-
Conant, K.1
Garzino-Demo, A.2
Nath, A.3
McArthur, J.C.4
Halliday, W.5
Power, C.6
Gallo, R.C.7
Major, E.O.8
-
33
-
-
0033546424
-
Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon
-
[33] Nath A, Conant K, Chen P, Scott C, Major EO. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem 1999; 274(24): 17098-17102.
-
(1999)
J Biol Chem
, vol.274
, Issue.24
, pp. 17098-17102
-
-
Nath, A.1
Conant, K.2
Chen, P.3
Scott, C.4
Major, E.O.5
-
34
-
-
0033807817
-
Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes
-
[34] Kutsch O, Oh J, Nath A, Benveniste EN. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol 2000; 74(19): 9214-9221.
-
(2000)
J Virol
, vol.74
, Issue.19
, pp. 9214-9221
-
-
Kutsch, O.1
Oh, J.2
Nath, A.3
Benveniste, E.N.4
-
35
-
-
55849095473
-
CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice
-
[35] El-Hage N, Bruce-Keller AJ, Knapp PE, Hauser KF. CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice. J Neuroimmune Pharmacol 2008; 3(4): 275-285.
-
(2008)
J Neuroimmune Pharmacol
, vol.3
, Issue.4
, pp. 275-285
-
-
El-Hage, N.1
Bruce-Keller, A.J.2
Knapp, P.E.3
Hauser, K.F.4
-
36
-
-
33644796067
-
HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines
-
[36] El-Hage N, Wu G, Wang J, Ambati J, Knapp PE, Reed JL, Bruce-Keller AJ, Hauser KF. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia 2006; 53(2): 132-146.
-
(2006)
Glia
, vol.53
, Issue.2
, pp. 132-146
-
-
El-Hage, N.1
Wu, G.2
Wang, J.3
Ambati, J.4
Knapp, P.E.5
Reed, J.L.6
Bruce-Keller, A.J.7
Hauser, K.F.8
-
37
-
-
58149339916
-
Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca2+]i, NF-κB trafficking and transcription
-
[37] El-Hage N, Bruce-Keller AJ, Yakovleva T, Bazov I, Bakalkin G, Knapp PE, Hauser KF. Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca2+]i, NF-κB trafficking and transcription. PLoS One 2008; 3(12): e4093.
-
(2008)
Plos One
, vol.3
, Issue.12
, pp. e4093
-
-
El-Hage, N.1
Bruce-Keller, A.J.2
Yakovleva, T.3
Bazov, I.4
Bakalkin, G.5
Knapp, P.E.6
Hauser, K.F.7
-
38
-
-
48249092325
-
Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia
-
[38] Turchan-Cholewo J, Dimayuga FO, Ding Q, Keller JN, Hauser KF, Knapp PE, Bruce-Keller AJ. Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. J Neurosci Res 2008; 86(9): 2100-2110.
-
(2008)
J Neurosci Res
, vol.86
, Issue.9
, pp. 2100-2110
-
-
Turchan-Cholewo, J.1
Dimayuga, F.O.2
Ding, Q.3
Keller, J.N.4
Hauser, K.F.5
Knapp, P.E.6
Bruce-Keller, A.J.7
-
39
-
-
0035808842
-
Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro
-
[39] Gurwell JA, Nath A, Sun Q, Zhang J, Martin KM, Chen Y, Hauser KF. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 2001; 102(3): 555-563.
-
(2001)
Neuroscience
, vol.102
, Issue.3
, pp. 555-563
-
-
Gurwell, J.A.1
Nath, A.2
Sun, Q.3
Zhang, J.4
Martin, K.M.5
Chen, Y.6
Hauser, K.F.7
-
40
-
-
3042791403
-
Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro
-
[40] Khurdayan VK, Buch S, El-Hage N, Lutz SE, Goebel SM, Singh IN, Knapp PE, Turchan-Cholewo J, Nath A, Hauser KF. Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. Eur J Neurosci 2004; 19(12): 3171-3182.
-
(2004)
Eur J Neurosci
, vol.19
, Issue.12
, pp. 3171-3182
-
-
Khurdayan, V.K.1
Buch, S.2
El-Hage, N.3
Lutz, S.E.4
Goebel, S.M.5
Singh, I.N.6
Knapp, P.E.7
Turchan-Cholewo, J.8
Nath, A.9
Hauser, K.F.10
-
41
-
-
0032068748
-
Opioids disrupt Ca2+ homeostasis and induce carbonyl oxyradical production in mouse astrocytes in vitro: Transient increases and adaptation to sustained exposure
-
[41] Hauser KF, Harris-White ME, Jackson JA, Opanashuk LA, Carney JM. Opioids disrupt Ca2+ homeostasis and induce carbonyl oxyradical production in mouse astrocytes in vitro: transient increases and adaptation to sustained exposure. Exp Neurol 1998; 151(1): 70-76.
-
(1998)
Exp Neurol
, vol.151
, Issue.1
, pp. 70-76
-
-
Hauser, K.F.1
Harris-White, M.E.2
Jackson, J.A.3
Opanashuk, L.A.4
Carney, J.M.5
-
42
-
-
33846245892
-
HIV-1 neuropathogenesis: Glial mechanisms revealed through substance abuse
-
[42] Hauser KF, El-Hage N, Stiene-Martin A, Maragos WF, Nath A, Persidsky Y, Volsky DJ, Knapp PE. HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse. J Neurochem 2007; 100(3): 567-586.
-
(2007)
J Neurochem
, vol.100
, Issue.3
, pp. 567-586
-
-
Hauser, K.F.1
El-Hage, N.2
Stiene-Martin, A.3
Maragos, W.F.4
Nath, A.5
Persidsky, Y.6
Volsky, D.J.7
Knapp, P.E.8
-
43
-
-
33748101228
-
CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates
-
[43] El-Hage N, Wu G, Ambati J, Bruce-Keller AJ, Knapp PE, Hauser KF. CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates. J Neuroimmunol 2006; 178(1-2): 9-16.
-
(2006)
J Neuroimmunol
, vol.178
, Issue.1-2
, pp. 9-16
-
-
El-Hage, N.1
Wu, G.2
Ambati, J.3
Bruce-Keller, A.J.4
Knapp, P.E.5
Hauser, K.F.6
-
44
-
-
33747458112
-
Impact of opiate-HIV-1 interactions on neurotoxic signaling
-
[44] Hauser KF, El-Hage N, Buch S, Nath A, Tyor WR, Bruce-Keller AJ, Knapp PE. Impact of opiate-HIV-1 interactions on neurotoxic signaling. J Neuroimmune Pharmacol 2006; 1(1): 98-105.
-
(2006)
J Neuroimmune Pharmacol
, vol.1
, Issue.1
, pp. 98-105
-
-
Hauser, K.F.1
El-Hage, N.2
Buch, S.3
Nath, A.4
Tyor, W.R.5
Bruce-Keller, A.J.6
Knapp, P.E.7
-
45
-
-
33644841358
-
Molecular targets of opiate drug abuse in neuroAIDS
-
[45] Hauser KF, El-Hage N, Buch S, Berger JR, Tyor WR, Nath A, Bruce-Keller AJ, Knapp PE. Molecular targets of opiate drug abuse in neuroAIDS. Neurotox Res 2005; 8(1-2): 63-80.
-
(2005)
Neurotox Res
, vol.8
, Issue.1
, pp. 63-80
-
-
Hauser, K.F.1
El-Hage, N.2
Buch, S.3
Berger, J.R.4
Tyor, W.R.5
Nath, A.6
Bruce-Keller, A.J.7
Knapp, P.E.8
-
46
-
-
57249086430
-
Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: Possible role in cytokine regulation
-
[46] Turchan-Cholewo J, Dimayuga FO, Gupta S, Keller JN, Knapp PE, Hauser KF, Bruce-Keller AJ. Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation. J Neurochem 2009; 108(1): 202-215.
-
(2009)
J Neurochem
, vol.108
, Issue.1
, pp. 202-215
-
-
Turchan-Cholewo, J.1
Dimayuga, F.O.2
Gupta, S.3
Keller, J.N.4
Knapp, P.E.5
Hauser, K.F.6
Bruce-Keller, A.J.7
-
47
-
-
84884906968
-
Morphine mediates a proinflammatory phenotype via mu-opioid receptor-PKCε-Akt-ERK1/2 signaling pathway in activated microglial cells
-
[47] Merighi S, Gessi S, Varani K, Fazzi D, Stefanelli A, Borea PA. Morphine mediates a proinflammatory phenotype via mu-opioid receptor-PKCε-Akt-ERK1/2 signaling pathway in activated microglial cells. Biochem Pharmacol 2013; 86(4): 487-496.
-
(2013)
Biochem Pharmacol
, vol.86
, Issue.4
, pp. 487-496
-
-
Merighi, S.1
Gessi, S.2
Varani, K.3
Fazzi, D.4
Stefanelli, A.5
Borea, P.A.6
-
48
-
-
33845428621
-
Buprenorphine and HIV primary care: New opportunities for integrated treatment
-
[48] Khalsa J, Vocci F, Altice F, Fiellin D, Miller V. Buprenorphine and HIV primary care: new opportunities for integrated treatment. Clin Infect Dis 2006; 43 Suppl 4: S169-172.
-
Clin Infect Dis 2006; 43 Suppl
, vol.4
, pp. S169-S172
-
-
Khalsa, J.1
Vocci, F.2
Altice, F.3
Fiellin, D.4
Miller, V.5
-
49
-
-
33845403539
-
The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention
-
[49] Altice FL, Sullivan LE, Smith-Rohrberg D, Basu S, Stancliff S, Eldred L. The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention. Clin Infect Dis 2006; 43 Suppl 4: S178-183.
-
Clin Infect Dis 2006; 43 Suppl
, vol.4
, pp. S178-S183
-
-
Altice, F.L.1
Sullivan, L.E.2
Smith-Rohrberg, D.3
Basu, S.4
Stancliff, S.5
Eldred, L.6
-
50
-
-
54049149928
-
The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: Evidence from the MANIF2000 cohort study
-
[50] Roux P, Carrieri MP, Villes V, Dellamonica P, Poizot-Martin I, Ravaux I, Spire B. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Addiction 2008; 103(11): 1828-1836.
-
(2008)
Addiction
, vol.103
, Issue.11
, pp. 1828-1836
-
-
Roux, P.1
Carrieri, M.P.2
Villes, V.3
Dellamonica, P.4
Poizot-Martin, I.5
Ravaux, I.6
Spire, B.7
-
51
-
-
44349097414
-
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors
-
[51] Sullivan LE, Moore BA, Chawarski MC, Pantalon MV, Barry D, O'Connor PG, Schottenfeld RS, Fiellin DA. Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. J Subst Abuse Treat 2008; 35(1): 87-92.
-
(2008)
J Subst Abuse Treat
, vol.35
, Issue.1
, pp. 87-92
-
-
Sullivan, L.E.1
Moore, B.A.2
Chawarski, M.C.3
Pantalon, M.V.4
Barry, D.5
O'connor, P.G.6
Schottenfeld, R.S.7
Fiellin, D.A.8
-
53
-
-
0037375255
-
Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection
-
[53] Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. Drug Alcohol Depend 2003; 69(3): 263-272.
-
(2003)
Drug Alcohol Depend
, vol.69
, Issue.3
, pp. 263-272
-
-
Umbricht, A.1
Hoover, D.R.2
Tucker, M.J.3
Leslie, J.M.4
Chaisson, R.E.5
Preston, K.L.6
-
54
-
-
78651494300
-
Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial
-
[54] Berg KM, Litwin A, Li X, Heo M, Arnsten JH. Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial. Drug Alcohol Depend 2011; 113(2-3): 192-199.
-
(2011)
Drug Alcohol Depend
, vol.113
, Issue.2
, pp. 192-199
-
-
Berg, K.M.1
Litwin, A.2
Li, X.3
Heo, M.4
Arnsten, J.H.5
-
55
-
-
84867761204
-
Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis
-
[55] MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, Degenhardt L, Hickman M. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ 2012; 345: e5945.
-
(2012)
BMJ
, pp. 345
-
-
Macarthur, G.J.1
Minozzi, S.2
Martin, N.3
Vickerman, P.4
Deren, S.5
Bruneau, J.6
Degenhardt, L.7
Hickman, M.8
-
56
-
-
22244462451
-
Buprenorphine: Clinical pharmacokinetics in the treatment of opioid dependence
-
[56] Elkader A, Sproule B. Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. Clin Pharmacokinet 2005; 44(7): 661-680.
-
(2005)
Clin Pharmacokinet
, vol.44
, Issue.7
, pp. 661-680
-
-
Elkader, A.1
Sproule, B.2
-
58
-
-
33748549289
-
Buprenorphine-containing treatments: Place in the management of opioid addiction
-
[58] Robinson SE. Buprenorphine-containing treatments: place in the management of opioid addiction. CNS Drugs 2006; 20(9): 697-712.
-
(2006)
CNS Drugs
, vol.20
, Issue.9
, pp. 697-712
-
-
Robinson, S.E.1
-
59
-
-
55549095137
-
Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: A randomized trial
-
[59] Woody GE, Poole SA, Subramaniam G, Dugosh K, Bogenschutz M, Abbott P, Patkar A, Publicker M, McCain K, Potter JS et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA 2008; 300(17): 2003-2011.
-
(2008)
JAMA
, vol.300
, Issue.17
, pp. 2003-2011
-
-
Woody, G.E.1
Poole, S.A.2
Subramaniam, G.3
Dugosh, K.4
Bogenschutz, M.5
Abbott, P.6
Patkar, A.7
Publicker, M.8
McCain, K.9
Potter, J.S.10
-
60
-
-
33845458075
-
Buprenorphine use: The international experience
-
[60] Carrieri MP, Amass L, Lucas GM, Vlahov D, Wodak A, Woody GE. Buprenorphine use: the international experience. Clin Infect Dis 2006; 43 Suppl 4: S197-215.
-
(2006)
Clin Infect Dis
, vol.43
, Issue.4
, pp. S197-S215
-
-
Carrieri, M.P.1
Amass, L.2
Lucas, G.M.3
Vlahov, D.4
Wodak, A.5
Woody, G.E.6
-
61
-
-
33750469017
-
The medical management of opioid dependence in HIV primary care settings
-
[61] Lum PJ, Tulsky JP. The medical management of opioid dependence in HIV primary care settings. Curr HIV/AIDS Rep 2006; 3(4): 195-204.
-
(2006)
Curr HIV/AIDS Rep
, vol.3
, Issue.4
, pp. 195-204
-
-
Lum, P.J.1
Tulsky, J.P.2
-
62
-
-
24644476431
-
Buprenorphine: Its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence
-
[62] Sullivan LE, Fiellin DA. Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence. Clin Infect Dis 2005; 41(6): 891-896.
-
(2005)
Clin Infect Dis
, vol.41
, Issue.6
, pp. 891-896
-
-
Sullivan, L.E.1
Fiellin, D.A.2
-
63
-
-
27244452980
-
Potential for abuse of buprenorphine in office-based treatment of opioid dependence
-
[63] Cicero TJ, Inciardi JA. Potential for abuse of buprenorphine in office-based treatment of opioid dependence. N Engl J Med 2005; 353(17): 1863-1865.
-
(2005)
N Engl J Med
, vol.353
, Issue.17
, pp. 1863-1865
-
-
Cicero, T.J.1
Inciardi, J.A.2
-
64
-
-
2342444349
-
Buprenorphine: A primer for emergency physicians
-
[64] Sporer KA. Buprenorphine: a primer for emergency physicians. Annals of emergency medicine 2004; 43(5): 580-584.
-
(2004)
Annals of Emergency Medicine
, vol.43
, Issue.5
, pp. 580-584
-
-
Sporer, K.A.1
-
65
-
-
27744513872
-
Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals
-
[65] Comer SD, Sullivan MA, Walker EA. Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals. J Pharmacol Exp Ther 2005; 315(3): 1320-1330.
-
(2005)
J Pharmacol Exp Ther
, vol.315
, Issue.3
, pp. 1320-1330
-
-
Comer, S.D.1
Sullivan, M.A.2
Walker, E.A.3
-
66
-
-
84855190955
-
The opiate analgesic buprenorphine decreases proliferation of adult hippocampal neuroblasts and increases survival of their progeny
-
[66] Pettit AS, Desroches R, Bennett SA. The opiate analgesic buprenorphine decreases proliferation of adult hippocampal neuroblasts and increases survival of their progeny. Neuroscience 2012; 200: 211-222.
-
(2012)
Neuroscience
, vol.200
, pp. 211-222
-
-
Pettit, A.S.1
Desroches, R.2
Bennett, S.A.3
-
67
-
-
84890847240
-
Prenatal buprenorphine exposure decreases neurogenesis in rats
-
[67] Wu CC, Hung CJ, Shen CH, Chen WY, Chang CY, Pan HC, Liao SL, Chen CJ. Prenatal buprenorphine exposure decreases neurogenesis in rats. Toxicology letters 2014; 225(1): 92-101.
-
(2014)
Toxicology Letters
, vol.225
, Issue.1
, pp. 92-101
-
-
Wu, C.C.1
Hung, C.J.2
Shen, C.H.3
Chen, W.Y.4
Chang, C.Y.5
Pan, H.C.6
Liao, S.L.7
Chen, C.J.8
-
68
-
-
84893187642
-
Depression-like effect of prenatal buprenorphine exposure in rats
-
[68] Hung CJ, Wu CC, Chen WY, Chang CY, Kuan YH, Pan HC, Liao SL, Chen CJ. Depression-like effect of prenatal buprenorphine exposure in rats. PLoS One 2013; 8(12): e82262.
-
(2013)
Plos One
, vol.8
, Issue.12
, pp. e82262
-
-
Hung, C.J.1
Wu, C.C.2
Chen, W.Y.3
Chang, C.Y.4
Kuan, Y.H.5
Pan, H.C.6
Liao, S.L.7
Chen, C.J.8
-
69
-
-
81155134840
-
Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid-and nociceptin/orphanin FQ receptors in cell development: Implications for drug addiction treatment during pregnancy
-
[69] Eschenroeder AC, Vestal-Laborde AA, Sanchez ES, Robinson SE, Sato-Bigbee C. Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid-and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy. Glia 2012; 60(1): 125-136.
-
(2012)
Glia
, vol.60
, Issue.1
, pp. 125-136
-
-
Eschenroeder, A.C.1
Vestal-Laborde, A.A.2
Sanchez, E.S.3
Robinson, S.E.4
Sato-Bigbee, C.5
-
70
-
-
51349159322
-
Opioid addiction and pregnancy: Perinatal exposure to buprenorphine affects myelination in the developing brain
-
[70] Sanchez ES, Bigbee JW, Fobbs W, Robinson SE, Sato-Bigbee C. Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain. Glia 2008; 56(9): 1017-1027.
-
(2008)
Glia
, vol.56
, Issue.9
, pp. 1017-1027
-
-
Sanchez, E.S.1
Bigbee, J.W.2
Fobbs, W.3
Robinson, S.E.4
Sato-Bigbee, C.5
-
71
-
-
58149393846
-
NMDA receptor activation by HIV-Tat protein is clade dependent
-
[71] Li W, Huang Y, Reid R, Steiner J, Malpica-Llanos T, Darden TA, Shankar SK, Mahadevan A, Satishchandra P, Nath A. NMDA receptor activation by HIV-Tat protein is clade dependent. J Neurosci 2008; 28(47): 12190-12198.
-
(2008)
J Neurosci
, vol.28
, Issue.47
, pp. 12190-12198
-
-
Li, W.1
Huang, Y.2
Reid, R.3
Steiner, J.4
Malpica-Llanos, T.5
Darden, T.A.6
Shankar, S.K.7
Mahadevan, A.8
Satishchandra, P.9
Nath, A.10
-
72
-
-
34249781154
-
Human immunodeficiency virus-restricted replication in astrocytes and the ability of gamma interferon to modulate this restriction are regulated by a downstream effector of the Wnt signaling pathway
-
[72] Carroll-Anzinger D, Kumar A, Adarichev V, Kashanchi F, Al-Harthi L. Human immunodeficiency virus-restricted replication in astrocytes and the ability of gamma interferon to modulate this restriction are regulated by a downstream effector of the Wnt signaling pathway. J Virol 2007; 81(11): 5864-5871.
-
(2007)
J Virol
, vol.81
, Issue.11
, pp. 5864-5871
-
-
Carroll-Anzinger, D.1
Kumar, A.2
Adarichev, V.3
Kashanchi, F.4
Al-Harthi, L.5
-
73
-
-
84866182299
-
Identification of novel T cell factor 4 (TCF-4) binding sites on the HIV long terminal repeat which associate with TCF-4, beta-catenin, and SMAR1 to repress HIV transcription
-
[73] Henderson LJ, Narasipura SD, Adarichev V, Kashanchi F, Al-Harthi L. Identification of novel T cell factor 4 (TCF-4) binding sites on the HIV long terminal repeat which associate with TCF-4, beta-catenin, and SMAR1 to repress HIV transcription. J Virol 2012; 86(17): 9495-9503.
-
(2012)
J Virol
, vol.86
, Issue.17
, pp. 9495-9503
-
-
Henderson, L.J.1
Narasipura, S.D.2
Adarichev, V.3
Kashanchi, F.4
Al-Harthi, L.5
-
74
-
-
84863116736
-
Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes
-
[74] Narasipura SD, Henderson LJ, Fu SW, Chen L, Kashanchi F, Al-Harthi L. Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes. J Virol 2012; 86(4): 1911-1921.
-
(2012)
J Virol
, vol.86
, Issue.4
, pp. 1911-1921
-
-
Narasipura, S.D.1
Henderson, L.J.2
Fu, S.W.3
Chen, L.4
Kashanchi, F.5
Al-Harthi, L.6
-
75
-
-
79959570407
-
IFN-gamma mediates enhancement of HIV replication in astrocytes by inducing an antagonist of the beta-catenin pathway (DKK1) in a STAT 3-dependent manner
-
[75] Li W, Henderson LJ, Major EO, Al-Harthi L. IFN-gamma mediates enhancement of HIV replication in astrocytes by inducing an antagonist of the beta-catenin pathway (DKK1) in a STAT 3-dependent manner. J Immunol 2011; 186(12): 6771-6778.
-
(2011)
J Immunol
, vol.186
, Issue.12
, pp. 6771-6778
-
-
Li, W.1
Henderson, L.J.2
Major, E.O.3
Al-Harthi, L.4
-
76
-
-
0030068995
-
Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic
-
[76] Nath A, Psooy K, Martin C, Knudsen B, Magnuson DS, Haughey N, Geiger JD. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 1996; 70(3): 1475-1480.
-
(1996)
J Virol
, vol.70
, Issue.3
, pp. 1475-1480
-
-
Nath, A.1
Psooy, K.2
Martin, C.3
Knudsen, B.4
Magnuson, D.S.5
Haughey, N.6
Geiger, J.D.7
-
77
-
-
78249278153
-
Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23
-
[77] Bakalkin G, Watanabe H, Jezierska J, Depoorter C, Verschuuren-Bemelmans C, Bazov I, Artemenko KA, Yakovleva T, Dooijes D, Van de Warrenburg BP et al. Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23. Am J Hum Genet 2010; 87(5): 593-603.
-
(2010)
Am J Hum Genet
, vol.87
, Issue.5
, pp. 593-603
-
-
Bakalkin, G.1
Watanabe, H.2
Jezierska, J.3
Depoorter, C.4
Verschuuren-Bemelmans, C.5
Bazov, I.6
Artemenko, K.A.7
Yakovleva, T.8
Dooijes, D.9
Van De Warrenburg, B.P.10
-
78
-
-
34249010261
-
Glial-restricted precursors: Patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro
-
[78] Buch SK, Khurdayan VK, Lutz SE, Knapp PE, El-Hage N, Hauser KF. Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro. Neuroscience 2007; 146(4): 1546-1554.
-
(2007)
Neuroscience
, vol.146
, Issue.4
, pp. 1546-1554
-
-
Buch, S.K.1
Khurdayan, V.K.2
Lutz, S.E.3
Knapp, P.E.4
El-Hage, N.5
Hauser, K.F.6
-
79
-
-
0021895138
-
A new generation of Ca2+ indicators with greatly improved fluorescence properties
-
[79] Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260(6): 3440-3450.
-
(1985)
J Biol Chem
, vol.260
, Issue.6
, pp. 3440-3450
-
-
Grynkiewicz, G.1
Poenie, M.2
Tsien, R.Y.3
-
80
-
-
79961033108
-
Diesel exhaust activates & primes microglia: Air pollution, neuroinflammation, & regulation of dopaminergic neurotoxicity
-
[80] Levesque S, Taetzsch T, Lull ME, Kodavanti U, Stadler K, Wagner A, Johnson JA, Duke L, Kodavanti P, Surace MJ et al. Diesel exhaust activates & primes microglia: air pollution, neuroinflammation, & regulation of dopaminergic neurotoxicity. Environ Health Perspect 2011; 119(8): 1149-55.
-
(2011)
Environ Health Perspect
, vol.119
, Issue.8
, pp. 1149-1155
-
-
Levesque, S.1
Taetzsch, T.2
Lull, M.E.3
Kodavanti, U.4
Stadler, K.5
Wagner, A.6
Johnson, J.A.7
Duke, L.8
Kodavanti, P.9
Surace, M.J.10
-
81
-
-
34250927314
-
On methods in the analysis of profile data
-
[81] Greenhouse SW, Geisser S. On methods in the analysis of profile data. Psychometrika 1959; 24: 95-112.
-
(1959)
Psychometrika
, vol.24
, pp. 95-112
-
-
Greenhouse, S.W.1
Geisser, S.2
-
82
-
-
0020408515
-
Sublingual buprenorphine used postoperatively: Ten hour plasma drug concentration analysis
-
[82] Bullingham RE, McQuay HJ, Porter EJ, Allen MC, Moore RA. Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis. Br J Clin Pharmacol 1982; 13(5): 665-673.
-
(1982)
Br J Clin Pharmacol
, vol.13
, Issue.5
, pp. 665-673
-
-
Bullingham, R.E.1
McQuay, H.J.2
Porter, E.J.3
Allen, M.C.4
Moore, R.A.5
-
83
-
-
1642292051
-
Desensitization of G protein-coupled receptors and neuronal functions
-
[83] Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 2004; 27: 107-144.
-
(2004)
Annu Rev Neurosci
, vol.27
, pp. 107-144
-
-
Gainetdinov, R.R.1
Premont, R.T.2
Bohn, L.M.3
Lefkowitz, R.J.4
Caron, M.G.5
-
84
-
-
40349114499
-
Agonist-selective mechanisms of GPCR desensitization
-
[84] Kelly E, Bailey CP, Henderson G. Agonist-selective mechanisms of GPCR desensitization. Br J Pharmacol 2008; 153 Suppl 1: S379-388.
-
(2008)
Br J Pharmacol
, vol.153
, Issue.1
, pp. S379-S388
-
-
Kelly, E.1
Bailey, C.P.2
Henderson, G.3
-
85
-
-
48249144810
-
Agonist-selective signaling is determined by the receptor location within the membrane domains
-
[85] Zheng H, Chu J, Qiu Y, Loh HH, Law PY. Agonist-selective signaling is determined by the receptor location within the membrane domains. Proc Natl Acad Sci U S A 2008; 105(27): 9421-9426.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, Issue.27
, pp. 9421-9426
-
-
Zheng, H.1
Chu, J.2
Qiu, Y.3
Loh, H.H.4
Law, P.Y.5
-
86
-
-
48149094331
-
Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression
-
[86] Finley MJ, Happel CM, Kaminsky DE, Rogers TJ. Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression. Cellular immunology 2008; 252(1-2): 146-154.
-
(2008)
Cellular Immunology
, vol.252
, Issue.1
, pp. 146-154
-
-
Finley, M.J.1
Happel, C.M.2
Kaminsky, D.E.3
Rogers, T.J.4
-
87
-
-
0029842870
-
Opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression
-
[87] Chao CC, Gekker G, Hu S, Sheng WS, Shark KB, Bu DF, Archer S, Bidlack JM, Peterson PK. κ opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression. Proc Natl Acad Sci U S A 1996; 93(15): 8051-8056.
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, Issue.15
, pp. 8051-8056
-
-
Chao, C.C.1
Gekker, G.2
Hu, S.3
Sheng, W.S.4
Shark, K.B.5
Bu, D.F.6
Archer, S.7
Bidlack, J.M.8
Peterson, P.K.9
-
88
-
-
0033990594
-
U50,488 protection against HIV-1-related neurotoxicity: Involvement of quinolinic acid suppression
-
[88] Chao CC, Hu S, Gekker G, Lokensgard JR, Heyes MP, Peterson PK. U50,488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression. Neuropharmacology 2000; 39(1): 150-160.
-
(2000)
Neuropharmacology
, vol.39
, Issue.1
, pp. 150-160
-
-
Chao, C.C.1
Hu, S.2
Gekker, G.3
Lokensgard, J.R.4
Heyes, M.P.5
Peterson, P.K.6
-
89
-
-
0025946539
-
Opiates, human peripheral blood mononuclear cells, and HIV
-
[89] Peterson PK, Sharp BM, Gekker G, Jackson B, Balfour HH, Jr. Opiates, human peripheral blood mononuclear cells, and HIV. Adv Exp Med Biol 1991; 288: 171-178.
-
(1991)
Adv Exp Med Biol
, vol.288
, pp. 171-178
-
-
Peterson, P.K.1
Sharp, B.M.2
Gekker, G.3
Jackson, B.4
Balfour, H.H.5
-
90
-
-
0025015430
-
Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures
-
[90] Peterson PK, Sharp BM, Gekker G, Portoghese PS, Sannerud K, Balfour HH, Jr. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS 1990; 4(9): 869-873.
-
(1990)
AIDS
, vol.4
, Issue.9
, pp. 869-873
-
-
Peterson, P.K.1
Sharp, B.M.2
Gekker, G.3
Portoghese, P.S.4
Sannerud, K.5
Balfour, H.H.6
-
91
-
-
33846650369
-
Buprenorphine for the treatment of opioid dependence
-
[91] Boothby LA, Doering PL. Buprenorphine for the treatment of opioid dependence. Am J Health Syst Pharm 2007; 64(3): 266-272.
-
(2007)
Am J Health Syst Pharm
, vol.64
, Issue.3
, pp. 266-272
-
-
Boothby, L.A.1
Doering, P.L.2
-
92
-
-
36649000019
-
Buprenorphine in the treatment of opioid dependence
-
[92] George S, Day E. Buprenorphine in the treatment of opioid dependence. Br J Hosp Med (Lond) 2007; 68(11): 594-597.
-
(2007)
Br J Hosp Med (Lond)
, vol.68
, Issue.11
, pp. 594-597
-
-
George, S.1
Day, E.2
-
93
-
-
64949102344
-
Buprenorphine/naloxone: A review of its use in the treatment of opioid dependence
-
[93] Orman JS, Keating GM. Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence. Drugs 2009; 69(5): 577-607.
-
(2009)
Drugs
, vol.69
, Issue.5
, pp. 577-607
-
-
Orman, J.S.1
Keating, G.M.2
-
94
-
-
64549140033
-
Buprenorphine: A review
-
[94] Wakhlu S. Buprenorphine: a review. J Opioid Manag 2009; 5(1): 59-64.
-
(2009)
J Opioid Manag
, vol.5
, Issue.1
, pp. 59-64
-
-
Wakhlu, S.1
-
95
-
-
0033821875
-
Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor
-
[95] Bloms-Funke P, Gillen C, Schuettler AJ, Wnendt S. Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor. Peptides 2000; 21(7):1141-1146.
-
(2000)
Peptides
, vol.21
, Issue.7
, pp. 1141-1146
-
-
Bloms-Funke, P.1
Gillen, C.2
Schuettler, A.J.3
Wnendt, S.4
-
96
-
-
0345552248
-
Agonistic effect of buprenorphine in a nociceptin/OFQ receptortriggered reporter gene assay
-
[96] Wnendt S, Kruger T, Janocha E, Hildebrandt D, Englberger W. Agonistic effect of buprenorphine in a nociceptin/OFQ receptortriggered reporter gene assay. Mol Pharmacol 1999; 56(2): 334-338.
-
(1999)
Mol Pharmacol
, vol.56
, Issue.2
, pp. 334-338
-
-
Wnendt, S.1
Kruger, T.2
Janocha, E.3
Hildebrandt, D.4
Englberger, W.5
-
97
-
-
4644245300
-
Buprenorphine: A unique drug with complex pharmacology
-
[97] Lutfy K, Cowan A. Buprenorphine: a unique drug with complex pharmacology. Current neuropharmacology 2004; 2(4): 395-402.
-
(2004)
Current Neuropharmacology
, vol.2
, Issue.4
, pp. 395-402
-
-
Lutfy, K.1
Cowan, A.2
-
98
-
-
84886857796
-
The role of orphanin FQ/nociceptin in neuroplasticity: Relationship to stress, anxiety and neuroinflammation
-
[98] Mallimo EM, Kusnecov AW. The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation. Frontiers in cellular neuroscience 2013; 7: 173.
-
(2013)
Frontiers in Cellular Neuroscience
, vol.7
, pp. 173
-
-
Mallimo, E.M.1
Kusnecov, A.W.2
-
99
-
-
33751549842
-
Regulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes
-
[99] Fu X, Zhu ZH, Wang YQ, Wu GC. Regulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes. Neuroscience 2007; 144(1): 275-285.
-
(2007)
Neuroscience
, vol.144
, Issue.1
, pp. 275-285
-
-
Fu, X.1
Zhu, Z.H.2
Wang, Y.Q.3
Wu, G.C.4
-
100
-
-
84906834240
-
Revolution in GPCR signalling: Opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10
-
[100] Fujita W, Gomes I, Devi LA. Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10. Br J Pharmacol 2014; 171(18): 4155-4176.
-
(2014)
Br J Pharmacol
, vol.171
, Issue.18
, pp. 4155-4176
-
-
Fujita, W.1
Gomes, I.2
Devi, L.A.3
-
101
-
-
0036679172
-
Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain
-
[101] Szabo I, Chen XH, Xin L, Adler MW, Howard OM, Oppenheim JJ, Rogers TJ. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci U S A 2002; 99(16): 10276-10281.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, Issue.16
, pp. 10276-10281
-
-
Szabo, I.1
Chen, X.H.2
Xin, L.3
Adler, M.W.4
Howard, O.M.5
Oppenheim, J.J.6
Rogers, T.J.7
-
102
-
-
9144231969
-
Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization
-
[102] Szabo I, Wetzel MA, Zhang N, Steele AD, Kaminsky DE, Chen C, Liu-Chen LY, Bednar F, Henderson EE, Howard OM et al. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. J Leukoc Biol 2003; 74(6): 1074-1082.
-
(2003)
J Leukoc Biol
, vol.74
, Issue.6
, pp. 1074-1082
-
-
Szabo, I.1
Wetzel, M.A.2
Zhang, N.3
Steele, A.D.4
Kaminsky, D.E.5
Chen, C.6
Liu-Chen, L.Y.7
Bednar, F.8
Henderson, E.E.9
Howard, O.M.10
-
103
-
-
84877283925
-
A bivalent ligand targeting the putative μ opioid receptor and chemokine receptor CCR5 heterodimers: Binding affinity versus functional activities
-
[103] Yuan Y, Arnatt CK, El-Hage N, Dever SM, Jacob JC, Selley DE, Hauser KF, Zhang Y. A bivalent ligand targeting the putative μ opioid receptor and chemokine receptor CCR5 heterodimers: binding affinity versus functional activities. MedChemComm 2013; 4(5): 847-851.
-
(2013)
Medchemcomm
, vol.4
, Issue.5
, pp. 847-851
-
-
Yuan, Y.1
Arnatt, C.K.2
El-Hage, N.3
Dever, S.M.4
Jacob, J.C.5
Selley, D.E.6
Hauser, K.F.7
Zhang, Y.8
-
104
-
-
84884502179
-
A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia
-
[104] El-Hage N, Dever SM, Podhaizer EM, Arnatt CK, Zhang Y, Hauser KF. A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia. AIDS 2013; 27(14): 2181-2190.
-
(2013)
AIDS
, vol.27
, Issue.14
, pp. 2181-2190
-
-
El-Hage, N.1
Dever, S.M.2
Podhaizer, E.M.3
Arnatt, C.K.4
Zhang, Y.5
Hauser, K.F.6
-
105
-
-
84876295705
-
Kreek MJ. Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history
-
[105] Proudnikov D, Randesi M, Levran O, Yuferov V, Crystal H, Ho A, Ott J, Kreek MJ. Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history. J Acquir Immune Defic Syndr 2013; 63(1): 17-26.
-
(2013)
J Acquir Immune Defic Syndr
, vol.63
, Issue.1
, pp. 17-26
-
-
Proudnikov, D.1
Randesi, M.2
Levran, O.3
Yuferov, V.4
Crystal, H.5
Ho, A.6
Ott, J.7
-
106
-
-
14844293853
-
Morphine potentiates HIV-1 gp120-induced neuronal apoptosis
-
[106] Hu S, Sheng WS, Lokensgard JR, Peterson PK. Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. J Infect Dis 2005; 191(6): 886-889.
-
(2005)
J Infect Dis
, vol.191
, Issue.6
, pp. 886-889
-
-
Hu, S.1
Sheng, W.S.2
Lokensgard, J.R.3
Peterson, P.K.4
-
107
-
-
0031854313
-
Opiates transdeactivate chemokine receptors: Delta and mu opiate receptor-mediated heterologous desensitization
-
[107] Grimm MC, Ben-Baruch A, Taub DD, Howard OM, Resau JH, Wang JM, Ali H, Richardson R, Snyderman R, Oppenheim JJ. Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. J Exp Med 1998; 188(2): 317-325.
-
(1998)
J Exp Med
, vol.188
, Issue.2
, pp. 317-325
-
-
Grimm, M.C.1
Ben-Baruch, A.2
Taub, D.D.3
Howard, O.M.4
Resau, J.H.5
Wang, J.M.6
Ali, H.7
Richardson, R.8
Snyderman, R.9
Oppenheim, J.J.10
-
108
-
-
0031737417
-
Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia
-
[108] Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 1998; 44(5): 831-835.
-
(1998)
Ann Neurol
, vol.44
, Issue.5
, pp. 831-835
-
-
Kelder, W.1
McArthur, J.C.2
Nance-Sproson, T.3
McClernon, D.4
Griffin, D.E.5
-
109
-
-
0033843359
-
Chemokine and chemokinereceptor expression in human glial elements: Induction by the HIV protein, Tat, and chemokine autoregulation
-
[109] McManus CM, Weidenheim K, Woodman SE, Nunez J, Hesselgesser J, Nath A, Berman JW. Chemokine and chemokinereceptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am J Pathol 2000; 156(4): 1441-1453.
-
(2000)
Am J Pathol
, vol.156
, Issue.4
, pp. 1441-1453
-
-
McManus, C.M.1
Weidenheim, K.2
Woodman, S.E.3
Nunez, J.4
Hesselgesser, J.5
Nath, A.6
Berman, J.W.7
-
110
-
-
32544437823
-
CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: A potential mechanism of HIV-CNS invasion and NeuroAIDS
-
[110] Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 2006; 26(4): 1098-1106.
-
(2006)
J Neurosci
, vol.26
, Issue.4
, pp. 1098-1106
-
-
Eugenin, E.A.1
Osiecki, K.2
Lopez, L.3
Goldstein, H.4
Calderon, T.M.5
Berman, J.W.6
-
111
-
-
0034332964
-
Astrocytes express functional chemokine receptors
-
[111] Dorf ME, Berman MA, Tanabe S, Heesen M, Luo Y. Astrocytes express functional chemokine receptors. J Neuroimmunol 2000; 111(1-2): 109-121
-
(2000)
J Neuroimmunol
, vol.111
, Issue.1-2
, pp. 109-121
-
-
Dorf, M.E.1
Berman, M.A.2
Tanabe, S.3
Heesen, M.4
Luo, Y.5
|